Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00134953
Status:
TERMINATED
Last Update Posted:
2007-12-17
First Post:
2005-08-23
Brief Title:
Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment
Status:
TERMINATED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The Principal Investigator left the clinic and there was no one who could take over this study
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is designed to investigate the efficacy and safety of rivastigmine compared with placebo in patients with mild cognitive impairment MCI
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None